Drugdiscovery >> Clinical Trials >> News
5604
Views
Cystic fibrosis drug candidate shows positive results in Phase 1A - drugdiscovery.com
Cystic fibrosis drug candidate shows positive results in Phase 1A - drugdiscovery.com


Celtaxsys’s experimental drug CTX-4430, intended for the treatment of pulmonary inflammation in CF, showed to be safe in healthy volunteers in the first of two clinical trials in Phase 1 program.
Read More >>


Tags: Cystic fibrosis, CF, clinical trial, experimental drug, Celtaxys - September 19, 2013
Related Articles
3415
Views
N30 Pharma starts a new trial for oral cystic fibrosis drug N30 Pharma starts a new trial for oral cystic fibrosis drug
N30 Phamra started the phase I clinical trial of N9115, a new cystic fibrosis drug.The study is randomized, placebo-controlled, double-blind and reached its final cohort. Read More >>

Tags: Clinical Trial,Cystic Fibrosis, Drugs, Fibrosis, Gene, Genetic, Pharmacokinetics, Placebo, Protein

4373
Views
Ventrus’ drug for anal fissures shows positive clinical results Ventrus’ drug for anal fissures shows positive clinical results
Diltiazem hydrochloride 2% cream (VEN 307) has been successful in two clinical dermal safety studies and one pharmacokinetic (PK) study. This paves way to new drug application (NDA) for VEN 307 as a t Read More >>

Tags: Ventrus, VEN 307, anal fissures, cream, new treatment, clinical trials

4474
Views
The results of Phase 1/2 study of Takeda’s norovirus vaccine candidate  The results of Phase 1/2 study of Takeda’s norovirus vaccine candidate
The intramuscular bivalent (GI/GII) norovirus vaccine candidate in healthy adults who were challenged with the most commonly occurring norovirus that causes gastroenteritis showed promise in a Phase 1 Read More >>

Tags: Takeda, vaccine, norovirus, gastroenteritis, clinical trial

4870
Views
GSK’s  malaria vaccine candidate shows promise in Phase 3 trial GSK’s malaria vaccine candidate shows promise in Phase 3 trial
According to the results of a large-scale Phase 3 trial, the vaccine candidate RTS,S, showed efficient at protecting young children and infants from clinical malaria up to 18 months after vaccination. Read More >>

Tags: GSK, malaria vaccine, malaria, RTS,S, clinical trial

4314
Views
T-DM1 drug beneficial for patients with advanced HER2 positive breast cancer T-DM1 drug beneficial for patients with advanced HER2 positive breast cancer
The results of the Phase 3 TH3RESA trial show that T-DM1, a conjugated monoclonal antibody in which trastuzumab is combined with a cell-killing drug emtansine (DM1), significantly improves the length Read More >>

Tags: T-DM1, breast cancer, advanced breast cancer, HER2 positive, combination drug, trastuzumab, emtansine, clinical trial

7153
Views
Promising results in Phase II clinical trials of Tirasemtiv in patients with ALS Promising results in Phase II clinical trials of Tirasemtiv in patients with ALS
Cytokinetics’ drug Tirasemtiv, a fast skeletal muscle troponin activator, shows safe and tolerable in two prior Phase 2 trials in patients with amyotrophic lateral sclerosis (ALS). The compound is Read More >>

Tags: Tirasemtiv, ALS, clinical trial, skeletal muscle troponin activator, amyotrophic lateral sclerosis, Cytokinetics

5007
Views
Humira as a treatment for hidradenitis suppurativa- the results of Phase 2 trial Humira as a treatment for hidradenitis suppurativa- the results of Phase 2 trial
According to the results of Phase 2 clnical trial, Humira induced a significant response rate, compared to placebo, in adult patients with moderate-to-severe hidradenitis suppurativa (HS). The drug Read More >>

Tags: Humira, AbbVie, hidradenitis suppurativa, clinical trial

5362
Views
Sidney Kimmel Comprehensive Cancer Center sponsors Phase II. trial of MK-3475 Sidney Kimmel Comprehensive Cancer Center sponsors Phase II. trial of MK-3475
Sidney Kimmel Comprehensive Cancer Center sponsors the phase II clinical trial of a new medicine which is used for treating MSI Positive Colorectal Cancer. Read More >>

Tags: MSI Positive Colorectal Cancer, cancer, Sidney Kimmel Comprehensive Cancer Center

7798
Views
Promising results of Reolysin in Phase 2 clinical trial in patients with squamous cell carcinoma of the lung Promising results of Reolysin in Phase 2 clinical trial in patients with squamous cell carcinoma of the lung
Oncolytics Biotech’s drug Reolysin, used in combination with carboplatin and paclitaxel, has shown high tumor shrinkage in patients with metastatic or recurrent squamous cell carcinoma of the lung Read More >>

Tags: Reolysin, clinical trial, squamous cell carcinoma of the lung, SCCLC, Oncolytics Biotech

5221
Views
New Alzheimer drug enters Phase 3 program New Alzheimer drug enters Phase 3 program
Lundbeck/ Otsuka Pharmaceutical’s investigational compound, Lu AE58054, is entering the first out of four Phase 3 clinical trials for the treatment of Alzheimer's disease. Lu AE58054 has a different Read More >>

Tags: Lundbeck, Otsuka, Alzheimer disease, investigational drug, new drug, treatment, clinical trial

MOST VIEWED
HOME | ABOUT | PRIVACY POLICY | TERMS & CONDITIONS | ADVERTISE | CONTACT
All rights reserved drugdiscovery.com 2013